FDA Approves EPINEPHRINE — Gland Pharma Limited
Gland Pharma Limited announced on Wednesday the FDA approval of its epinephrine injection for intramuscular use, API ANDA219239. This authorization expands the competitive landscape for emergency allergy treatments, likely pressuring market prices as multiple generic manufacturers vie for commercial share.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed